Friday, January 27, 2023
HomeLifestyle'Robust evidence' Covid blood-thinning drug does more harm than good, concludes new...

'Robust evidence' Covid blood-thinning drug does more harm than good, concludes new study

[ad_1]

The reason why patients have been given blood thinning medications such as Apixaban is because doctors hoped they would reduce the risk of blood clots – a condition Covid has been found to increase the risk of.

However, during this trial, several of the 402 participants began to experience serious bleeding as a result, forcing them to stop taking Apixaban.

Furthermore, the team also found that 30.8 percent of Covid patients who received standard care were back in hospital less than a year later. This compares to 29.1 percent of patients on Apixaban.

Due to the small difference, the positives of Apixaban are limited, adding to the body of evidence against its usage.

READ MORE: Three drinks linked to an ‘extensive’ build-up of plaque in the veins



[ad_2]

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular